Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Revenue (2020 - 2026)

Updated

Recursion Pharmaceuticals' Revenue came in at $7.67 million for Q2 2026, down 60.1% from $19.22 million a year earlier but up 18.5% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Revenue (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Recursion Pharmaceuticals reported Revenue of $54.86 million, down 15.1% year-over-year; for FY2025, it was $74.68 million, up 26.9% from FY2024.

  • Revenue has increased in each of the last six years, with a five-year compound annual growth rate of 79.9% (FY2020 to FY2025).
  • Going back by year, Revenue was $58.84 million in FY2024 (+32.0%), $44.58 million in FY2023 (+11.9%), $39.84 million in FY2022 (+291.5%) and $10.18 million in FY2021 (+156.9%).
  • The five-year range for quarterly Revenue is $2.53 million (Q4 2021) to $35.54 million (Q4 2025).
  • Year-over-year, Revenue increased in four of the last eight quarters, with growth averaging 76.9%.
  • The fastest year-over-year change in Revenue over five years came in Q4 2025 (growth of 681.7%), and the weakest in Q3 2025 (a decline of 80.2%).
  • Business Quant data shows RXRX's Revenue at $6.47 million (Q1 2026), $35.54 million (Q4 2025) and $5.18 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn 7.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.67 Mn
Mar 31, 2026 6.47 Mn
Dec 31, 2025 35.54 Mn
Sep 30, 2025 5.18 Mn
Jun 30, 2025 19.22 Mn
Mar 31, 2025 14.75 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 26.08 Mn
Jun 30, 2024 14.42 Mn
Mar 31, 2024 13.79 Mn
Dec 31, 2023 10.89 Mn
Sep 30, 2023 10.53 Mn
Jun 30, 2023 11.02 Mn
Mar 31, 2023 12.13 Mn
Dec 31, 2022 13.68 Mn
Sep 30, 2022 13.16 Mn
Jun 30, 2022 7.67 Mn
Mar 31, 2022 5.33 Mn
Dec 31, 2021 2.53 Mn
Sep 30, 2021 2.53 Mn
API Access

Recursion Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RXRX&period=max&api_key=YOUR_API_KEY